Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus

There have been conflicting results regarding the effect of proton pump inhibitors (PPIs) as an adjunctive therapy to oral antidiabetic medication (OAM) in those with type 2 diabetes (T2DM). PPIs increase gastrin levels, causing a rise in insulin. No studies have evaluated the duration of PPI therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Trang, Amy, Bushman, Jordan, Halalau, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346311/
https://www.ncbi.nlm.nih.gov/pubmed/34368365
http://dx.doi.org/10.1155/2021/5578265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346311/
https://www.ncbi.nlm.nih.gov/pubmed/34368365
http://dx.doi.org/10.1155/2021/5578265

Ejemplares similares